29 result(s) for 'Immunofluorescence'
11 - 20 of 29 results for 'Immunofluorescence'
Sort by
Show
Incorporation and Automation of RNAscope Technology into your COVID-19 Viral Pathogenesis Research. Research Use Only, Not for Clinical Diagnostic Procedure
For Research Use Only. Not For Diagnostic Use. Incorporation of the highly sensitive and specific RNAscope technology into your COVID-19 Viral Pathogenesis Research Jyoti Sheldon Applications Research Use Only, Not for Clinical Diagnostic Procedure
Agenda RNAscope technology overview COVID-19 Offerings COVID-19 Publications Research Use Only, Not for Clinical Diagnostic Procedure
RNAscope®In Situ Hybridization (ISH) Technology A hybridization-based signal amplification system with a unique probe design - Simultaneous signal amplification and background suppression Amplification Target-specific binding A specific and sensit...
Following a PhD and postdoc in the field of developmental neurobiology, I joined the experimental histopathology team at the Crick in 2017. Within the science technology platform, I primarily lead on the development and application of advanced staining techniques including immunohistochemistry, immunofluorescence, multiplexed staining, and RNAscope.
Chifei is a senior histotechnologist with GSK R&D. He has broad knowledge and technical skills in routine histology, immunohistochemistry, multiplex immunofluorescence, digital pathology and quantitative image analysis. His work scopes from target validation, animal model characterization to clinical biomarker assay development and validation. He has a master’s degree in neurobiology from Fudan University and a bachelor’s degree in biology from Shandong University in China.
The content of this webinar will encompass detailed technical descriptions of novel and state of the art methods to decalcify tissue samples that will be embedded in paraffin or for frozen sectioning for molecular and nucleic acid analysis for basic research...
Stephanie is a Lecturer in Precision Medicine at the Patrick G. Johnson Centre for Cancer Research, Queen’s University Belfast. She has a breath of experience in the application and validation of translational cancer research methodologies using molecular pathology techniques (immunohistochemistry, in situ hybridisation, multiplex immunofluorescence) and statistics. Her research focuses on predictive biomarker studies and understanding confounding variables that influence the prediction of poor prognosis subgroups in cancer research including reproducible study design, choice of molecular test and assessment criteria.